Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.000
+0.100 (3.45%)
At close: Jul 2, 2026, 4:00 PM EDT
2.990
-0.010 (-0.33%)
After-hours: Jul 2, 2026, 4:10 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $132.78 million as of July 2, 2026. Its market cap has increased by 17.87% in one year.
Market Cap
132.78M
Enterprise Value
109.07M
1-Year Change
17.87%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $132.78M, a decrease of -6.29%. That is a compound annual growth rate of -1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 132.78M | -19.04% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 138.64M |
| Cue Biopharma | 135.53M |
| Enlivex | 132.89M |
| Spero Therapeutics | 129.41M |
| Polaryx Therapeutics | 129.25M |
| Unicycive Therapeutics | 129.23M |
| Agenus | 129.09M |
| Aldeyra Therapeutics | 126.81M |